Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy

The risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)-negative, antibody to hepatitis B core antigen (anti-HBc)-positive patients after glucocorticoid (GC) pulse therapy remains unclear. Aims: Our study aimed to examine the safety of GC pulse therapy in HBsAg-negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Cheng, Chen, Yen-Ju, Lee, Shou-Wu, Lee, Teng-Yu, Chen, Yi-Hsing, Huang, Wen-Nan, Yang, Sheng-Shun, Chen, Yi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347429/
https://www.ncbi.nlm.nih.gov/pubmed/34362079
http://dx.doi.org/10.3390/jcm10153296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347429/
https://www.ncbi.nlm.nih.gov/pubmed/34362079
http://dx.doi.org/10.3390/jcm10153296

Ejemplares similares